IL6 and melanoma: Elevated baseline levels of cytokines in melanoma patients have been mainly studied for IL-6 and IL-10, with elevated initial levels of IL-10 being associated with increased mortality, while a progressive increase in IL-6 predicts a worse prognosis in melanoma.